CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-10 | BERGER FRANKLIN M Director | Sale | −359,606 | $2.85 | $1.0M | 451,897 |
| 2024-09-19 | Sommadossi Jean-Pierre President, CEO, and Chairman | Sale 10b5-1 | −1,841 | $4.00 | $7K | 5,866,025 |
| 2024-09-18 | Sommadossi Jean-Pierre President, CEO, and Chairman | Sale 10b5-1 | −22,187 | $4.03 | $89K | 5,867,866 |
| 2024-09-17 | Sommadossi Jean-Pierre President, CEO, and Chairman | Sale 10b5-1 | −33,941 | $4.05 | $137K | 5,890,053 |
| 2024-06-20 | Polsky Bruce Director | Sale | −17,544 | $3.49 | $61K | 65,606 |
| 2024-06-05 | Sommadossi Jean-Pierre President, CEO, and Chairman | Sale 10b5-1 | −1,006 | $4.00 | $4K | 5,923,994 |
| 2024-02-01 | Corcoran Andrea See Remarks | Sale | −15,843 | $3.84 | $61K | 670,208 |
| 2024-02-01 | Sommadossi Jean-Pierre President, CEO, and Chairman | Sale 10b5-1 | −56,910 | $3.85 | $219K | 116,557 |
| 2024-02-01 | Horga Maria Arantxa Chief Medical Officer | Sale | −15,870 | $3.84 | $61K | 25,664 |
| 2024-02-01 | Foster Wayne EVP, Chief Accounting Officer | Sale | −12,477 | $3.84 | $48K | 20,857 |
| 2024-02-01 | Vavricka John Chief Commercial Officer | Sale | −11,819 | $3.84 | $45K | 21,515 |
| 2024-02-01 | Hammond Janet MJ Chief Development Officer | Sale | −14,029 | $3.84 | $54K | 35,362 |
| 2022-11-14 | BERGER FRANKLIN M Director | Sale | −16,166 | $5.16 | $83K | 778,353 |
| 2022-11-11 | BERGER FRANKLIN M Director | Sale | −25,500 | $5.15 | $131K | 794,519 |
Page 1 of 1 · 14 trades